文献速递主动脉疾病

现成多分支内移植物与定制器械相比在肾旁腹主动脉瘤腔内修复中需要额外主动脉覆盖

Additional Aortic Coverage With an Off The Shelf, Multibranched Endograft Compared With Custom Made Devices For Endovascular Repair of Pararenal Abdominal Aortic Aneurysms.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2023-01-24

该回顾性单中心研究纳入83例肾旁腹主动脉瘤患者,均接受定制器械(Zenith Fenestrated)治疗,并模拟249例次现成多分支内移植物(T-Branch、E-nside、TAMBE)治疗。与定制器械相比,现成器械需要从腹腔干起始平均额外74±19 mm的近端健康主动脉覆盖(定制器械33±19 mm vs 现成器械108±6 mm,p≤.001),并平均额外牺牲2.5条节段动脉(定制器械1.3±0.8 vs 现成器械3.8±0.9,p≤.001)。

要点

  • 现成多分支内移植物较定制器械平均需额外74±19 mm近端健康主动脉覆盖。
  • 现成器械平均额外牺牲2.5条节段动脉(定制器械1.3±0.8 vs 现成器械3.8±0.9)。
  • 94%患者至少一种现成多分支内移植物可按说明书植入。

核心结论

  • 尽管现成内移植物无需定制时间,但用于治疗肾旁腹主动脉瘤时,与定制器械相比导致更广泛的健康主动脉覆盖,并平均额外牺牲2.5条节段动脉。
  • 与现成器械相比,定制器械似乎限制了不必要的主动脉覆盖范围及理论上的后续脊髓缺血风险。

研究设计与样本

  • 回顾性单中心分析前瞻性收集的数据。
  • 纳入2017年1月至2021年12月期间连续计划并接受定制器械(Zenith Fenestrated)治疗、需要腹腔干以上近端锚定区的肾旁腹主动脉瘤患者。
  • 使用术前影像模拟现成多分支器械(T-Branch、E-nside、TAMBE)的腹腔干以上覆盖治疗。
  • 共83例患者接受定制器械治疗(均为开窗腔内主动脉修复),并模拟249例次(3×83)现成内移植物治疗。

主要发现

  • 83例患者包括近肾腹主动脉瘤46例(56%)、肾上腹主动脉瘤20例(24%)和短颈腹主动脉瘤17例(20%)。
  • 与定制器械相比,现成器械需要从腹腔干起始平均额外74±19 mm的近端健康主动脉覆盖(定制器械33±19 mm vs 现成器械108±6 mm,p≤.001)。
  • 与定制器械相比,现成器械平均额外牺牲2.5条节段动脉(定制器械1.3±0.8 vs 现成器械3.8±0.9,p≤.001)。
  • 94%的患者至少一种可用的多分支内移植物可按说明书植入。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pararenal abdominal aortic aneurysms (p-AAA) require complex endovascular aortic repair or open surgical repair with suprarenal clamping. Custom made devices (CMD), including fenestrated and branched endovascular aortic repair (F/B-EVAR) or off the shelf (OTS) multibranched devices, are available treatment options. The aim of this study was to determine the additional healthy aortic coverage using an OTS multibranched endograft vs. a CMD for the treatment of p-AAAs. METHODS: This was a retrospective single centre analysis of prospectively collected data. Consecutive patients with p-AAAs requiring a proximal landing zone above the coeliac artery (CA), planned and treated with CMDs (Zenith Fenestrated) between January 2017 and December 2021 were included in this study. Treatment with supracoeliac coverage using available OTS multibranched devices was simulated using available pre-operative images: T-Branch; E-nside; and TAMBE. Study endpoints included the need for additional proximal aortic coverage, and the number of the segmental arteries additionally covered proximally from the CA for OTS devices compared with CMDs. RESULTS: Eighty three patients with p-AAAs were treated with CMDs (all FEVAR), including juxtarenal AAAs (n = 46; 56%), suprarenal AAAs (n = 20; 24%), and short neck AAAs (n = 17; 20%). In this study, treatment with 249 (3 × 83) OTS endografts was simulated. When compared with CMDs, OTS devices required a mean of 74 ± 19 mm of additional proximal healthy aortic coverage from the CA (CMD: 33 ± 19 mm vs. OTS: 108 ± 6 mm; p ≤ .001), as well as an average sacrifice of 2.5 additional segmental arteries (CMD: 1.3 ± 0.8 vs. OTS: 3.8 ± 0.9; p ≤ .001). In 94% of patients, at least one of the available multibranched endografts could have been implanted in accordance with instructions for use. CONCLUSION: Despite not requiring customisation time, OTS endografts for the treatment of p-AAA lead to more extensive healthy aortic coverage, as well as an average sacrifice of 2.5 additional segmental arteries, compared with CMDs. When compared with OTS devices, CMDs appear to limit the extent of unnecessary aortic coverage and the theoretical subsequent risk of spinal cord ischaemia.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Spath P, Tsilimparis N, Furlan F, et al. Additional Aortic Coverage With an Off The Shelf, Multibranched Endograft Compared With Custom Made Devices For Endovascular Repair of Pararenal Abdominal Aortic Aneurysms. Eur J Vasc Endovasc Surg. 2023. PMID: 36707021. doi:10.1016/j.ejvs.2023.01.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。